In Aspen, a Bipartisan Strategy for Ibogaine Takes Shape, as Advocates Confront Limits of Traditional Rehab

Ibogaine advocacy in Aspen brought together a bipartisan coalition focused on reducing addiction harms by challenging the limits of standard rehab. Attendees framed the opioid crisis and rising PTSD among veterans as creating uncommon political alignment, with Americans for Ibogaine convening researchers, lawmakers, veterans groups, and strategists to build a new treatment and policy system. Texas was treated as a blueprint, with advocates emphasizing early bipartisan champions, managing opposition, and using institutional credibility from research partners to support legislation. The discussions also stressed the high costs of repeated failed rehab attempts and argued that ibogaine stands out because it may interrupt opioid dependence after a single administration, though it is not a “one-shot” fix. Participants focused on communications strategy, safety standards, and long post-care timelines, including the need for unified best practices across clinics. Colorado was highlighted as a possible next mover, while groups urged ethical engagement around Gabon’s traditional iboga use and observational research. The gathering was described as a turning point toward a workable policy and implementation roadmap rather than consensus.